Notable Downgrades: Alexion Pharma (ALXN), Marvell Technology (MRVL), Solera Holdings (SLH), Seattle Genetics (SGEN), XPO Logistics (XPO)

Analysts at Barclays downgraded Alexion Pharmaceuticals, Inc. (ALXN) from ‘Overweight’ to ‘Equal Weight’ in a research report issued to clients on Monday.

The target price for ALXN is lowered from $220 to $205.

On valuation measures, Alexion Pharmaceuticals Inc. stock it’s trading at a forward P/E multiple of 27.59x, and at a multiple of 56.78x this year’s estimated earnings. The t-12-month revenue at Alexion is $2.39 billion. ALXN ‘s ROE for the same period is 10.37%.

Shares of the $37.60 billion market cap company are up 2.98% year-over-year ; down 7.08% year-to-date.

Alexion Pharmaceuticals Inc., currently with a median Wall Street price target of $224.00 and a high target of $257.00, dropped $5.56 to $166.37 in recent trading.

The chart below shows where the equity has traded over the past 52-weeks.

Marvell Technology Group Ltd. (MRVL) was downgraded from ‘Buy’ to ‘Hold’ at Needham. The broker also cut its price target on the name to $9.50 from $17.50 based on last week’s investigation into accounting issues.

Shares have traded today between $8.44 and $8.70 with the price of the stock fluctuating between $8.21 to $16.78 over the last 52 weeks.

Marvell Technology Group Ltd. shares have a t-12 price/sales ratio of 1.42. EPS for the same period registers at ($0.33).

Shares of Marvel Technology have lost $0.27 to $8.57 in midday trading on Monday, giving it a market cap of $4.43 billion. The stock traded as high as $16.78 in Feb. 20, 2015.

Barrington Research reported on Monday that they have lowered their rating for Solera Holdings Inc. (SLH). The firm has downgraded SLH from ‘Market Perform’ to ‘Underperform’.

Solera Holdings Inc. recently traded at $53.68, a gain of $4.23 over Friday’s closing price. The name has a current market capitalization of $3.60 billion.

As for passive income investors, the company pays shareholders $0.90 per share annually in dividends, yielding 1.82%.

Seattle Genetics, Inc. (SGEN) was reiterated a ‘Outperform’ by RBC Capital Markets analysts on Monday. The broker however, cut its price target on the stock to $54 from $56.

SGEN shares recently gained $1.65 to $46.66. In the past 52 weeks, shares of Bothell, Washington-based biotechnology company have traded between a low of $30.05 and a high of $52.33.

Shares are up 10.05% year-over-year and 40% year-to-date.

XPO Logistics, Inc. (XPO) was reiterated as ‘Outperform’ with a $50 from $55 price target on Monday by Cowen.

XPO shares recently lost 1.29 to $30.96. The stock is down more than 5% year-over-year and has lost roughly 21% year-to-date. Over the past year, shares of Greenwich, Connecticut-based transportation and logistics services company have traded between a low of $28.91 and a high of $50.96.

XPO Logistics, Inc. closed Friday at $32.25. The name has a current market cap of $2.95 billion.

Be the first to comment

Leave a Reply

Your email address will not be published.


*